Zydus Lifesciences Stock Scales New 52-Week Peak at Rs 1,207: Key Reasons Behind the Surge
- September 25, 2026
- Posted by: Harsh Piplani
- Category: News
Zydus Lifesciences Share Price moved to Rs 1,201 today, up 1.78% from the previous close of Rs 1,180, after touching a fresh 52-week high of Rs 1,206.8. The company’s market capitalisation stands at Rs 1,16,658.07 crore. The latest Zydus Lifesciences Share Price move is relevant because it confirms a new yearly high in the stock without implying any company-specific reason beyond the supplied data. For investors tracking Zydus Lifesciences Share Price Today, the verified numbers show a higher session range, a positive close, and a sizeable listed-company footprint in the healthcare space. Univest is following the event as part of its Zydus Lifesciences Stock News coverage.
Zydus Lifesciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,201 |
| Previous Close | Rs 1,180 |
| Today's Move | +Rs 21 (+1.78%) |
| Open | Rs 1,187.7 |
| High | Rs 1,206.8 |
| Low | Rs 1,183.35 |
| Turnover | Rs 5.2 crore |
| Market Capitalisation | Rs 1,16,658.07 crore |
Zydus Lifesciences Ltd. (ZYDUSLIFE) traded at Rs 1,201 versus the previous close of Rs 1,180, a rise of 1.78%. The stock opened at Rs 1,187.7, reached a high of Rs 1,206.8 and touched a low of Rs 1,183.35.
Zydus Lifesciences Share Price opened at Rs 1,187.7, moved between Rs 1,183.35 and Rs 1,206.8 during the session, and closed at Rs 1,201. That leaves the stock Rs 21 above the previous close of Rs 1,180, matching a day change of 1.78%. The session high equals the fresh 52-week high, so today’s price event is a clear one-year high in Zydus Lifesciences Share Price terms. Turnover for the session stood at Rs 5.2 crore, which is the only traded-value measure to read alongside the price move. For readers scanning Zydus Lifesciences Share Price Today, the verified data confirms the stock finished near its session high and at a new yearly high. Univest will continue to track Zydus Lifesciences Share Price Live and Zydus Lifesciences Share Price Update as the market digests this move.
Zydus Lifesciences Ltd. (ZYDUSLIFE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,16,658.07 crore |
| P/E Ratio | 26.08x |
| P/B Ratio | 4.37x |
| ROE | 19.69% |
| ROCE | 21.39% |
| EPS | Rs 45.24 |
| Book Value Per Share | Rs 270.31 |
| Dividend Yield | 0.08% |
Zydus Lifesciences Ltd. (ZYDUSLIFE) fundamental metrics show P/E 26.08x, P/B 4.37x, ROE 19.69%, ROCE 21.39%. These figures provide context only and are not a buy or sell signal.
Zydus Lifesciences Ltd. has a market capitalisation of Rs 116658.07 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 26.08x, P/B at 4.37x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.69% and ROCE of 21.39%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 45.24, book value per share of Rs 270.31, dividend yield of 0.08%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.73x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 26.08x |
| Benchmark Median P/E | 32.73x |
| Benchmark Average P/E | 49.72x |
| Benchmark P/E Range | 3.48x to 757.76x |
| Company P/B Ratio | 4.37x |
| Benchmark Median P/B | 2.94x |
| Company ROE | 19.69% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 21.39% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 1,16,658.07 crore |
| Benchmark Median Market Cap | Rs 793.62 crore |
Zydus Lifesciences Ltd. (ZYDUSLIFE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 26.08x, which is below the benchmark median of 32.73x, a difference of -20.32%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROE of 19.69%, which is above the benchmark median of 11.7%, a difference of +68.29%. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROCE of 21.39%, which is above the benchmark median of 13.46%, a difference of +58.92%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Cipla Ltd. | CIPLA | 1,11,484.47 | 33.65 | 3.23 | 11.83 | 16 |
| Laurus Labs Ltd. | LAURUSLABS | 1,09,942.73 | 100.13 | 19.41 | 18.31 | 18.2 |
| Mankind Pharma Ltd. | MANKIND | 1,01,712.35 | 50.05 | 6.08 | 12.69 | 13.24 |
| Dr. Reddy's Laboratories Ltd. | DRREDDY | 1,01,004.66 | 31.1 | 2.62 | 11.69 | 13.75 |
| Aurobindo Pharma Ltd. | AUROPHARMA | 99,252.69 | 26.66 | 2.54 | 9.93 | 12.76 |
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 26.08x compared with the displayed peer median of 33.65x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 19.69% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 21.39% versus the displayed peer median of 13.75%, providing a capital-efficiency comparison. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a market capitalisation of Rs 1,16,658.07 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Zydus Lifesciences
- Zydus Lifesciences Share Price closed at Rs 1,201 after touching a fresh 52-week high of Rs 1,206.8.
- The stock was Rs 21 higher than the previous close, translating into a 1.78% rise for the day.
- Market capitalisation stood at Rs 1,16,658.07 crore, giving a large listed-company base in the healthcare sector.
- P/E was 26.08, below the same-industry median of 32.73 and average of 49.72.
- ROE of 19.69% and ROCE of 21.39% were both above the same-industry medians supplied in the sector snapshot.
About Zydus Lifesciences
Zydus Lifesciences Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data identifies it as a listed Indian company on NSE and BSE under the symbol ZYDUSLIFE. In the context of Zydus Lifesciences Company News, the article uses only the verified financial, sector and peer data supplied in the workflow. Univest presents this as part of its Zydus Lifesciences Latest News and Zydus Lifesciences Market Cap coverage, with the aim of keeping the company profile factual and concise. For readers comparing Zydus Lifesciences Share Price with sector benchmarks, the company sits within a broad pharmaceuticals universe and is supported by the disclosed earnings and return metrics.
Track Zydus Lifesciences Share Price on Univest
Use Zydus Lifesciences Ltd. (ZYDUSLIFE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Zydus Lifesciences Share Price on Univest for live price updates, company fundamentals, shareholding pattern, market capitalisation, 52-week levels and stock insights. Univest also helps readers follow Zydus Lifesciences Share Price Today, Zydus Lifesciences Stock News and Zydus Lifesciences Share Price Update in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What happened to Zydus Lifesciences Share Price today?
Ans. Zydus Lifesciences Share Price ended at Rs 1,201, up 1.78% from the previous close of Rs 1,180. The stock also touched Rs 1,206.8 during the session, which is the fresh 52-week high.
What is the fresh 52-week high for Zydus Lifesciences?
Ans. The fresh 52-week high for Zydus Lifesciences was Rs 1,206.8. The close at Rs 1,201 sits just below that level, so the stock finished the session near its yearly high.
What does the turnover figure show for Zydus Lifesciences Share Price today?
Ans. Turnover stood at Rs 5.2 crore. It is a traded-value measure, so it helps describe the session in factual terms alongside the day’s price change, open, low and high. The stock moved 1.78% during the session.
How does Zydus Lifesciences compare on valuation with its industry?
Ans. Zydus Lifesciences has a P/E of 26.08 versus the industry median of 32.73 and average of 49.72. Its P/B of 4.37 is above the industry median of 2.94 and equal to the average.
What do ROE and ROCE say about Zydus Lifesciences?
Ans. ROE is 19.69% and ROCE is 21.39%. Both are above the same-industry medians of 11.7% and 13.46%, which provides useful profitability and capital-return context for Zydus Lifesciences Share Price. ROE stands at 19.69%.
How do EPS, book value and dividend yield look for Zydus Lifesciences?
Ans. EPS is Rs 45.24, book value per share is Rs 270.31 and dividend yield is 0.08%. These three numbers give a clear snapshot of earnings, accounting net worth and historical payout context.
How does Zydus Lifesciences compare with peers on market cap?
Ans. Zydus Lifesciences has a market capitalisation of Rs 1,16,658.07 crore, which is above the peer figures supplied for Cipla, Laurus Labs, Mankind Pharma, Dr. Reddy’s Laboratories and Aurobindo Pharma in this dataset.
